Diclofenac Sodium
- Product NDC
- 53002-5361
- 11-digit product format
- 530025361
- Labeler code
- 53002
- Product ID
- 53002-5361_8b89d61e-35eb-402a-a977-43386fa099df
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Diclofenac Sodium
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA074514
- Marketing category
- ANDA
- Marketing start
- 1996-03-26
- Marketing end
- 0000-00-00
- Substance
- DICLOFENAC SODIUM
- Active strength
- 75 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-5361-1 | 53002536101 | 10 TABLET, DELAYED RELEASE in 1 BOTTLE (53002-5361-1) | 2019-01-01 | 0000-00-00 | No | No | Current |
| 53002-5361-2 | 53002536102 | 20 TABLET, DELAYED RELEASE in 1 BOTTLE (53002-5361-2) | 2019-01-01 | 0000-00-00 | No | No | Current |
| 53002-5361-3 | 53002536103 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (53002-5361-3) | 2019-01-01 | 0000-00-00 | No | No | Current |
| 53002-5361-5 | 53002536105 | 15 TABLET, DELAYED RELEASE in 1 BOTTLE (53002-5361-5) | 2019-01-01 | 0000-00-00 | No | No | Current |